HL-085 in NRAS-mutated Advanced Melanoma
Clinical trial NCT05217303 · COMPLETED
Trial details
- NCT number
- NCT05217303
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2023-02-19
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.